Related Experiment Video
Updated: Aug 8, 2026

09:30
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
Published on: October 7, 2016
Development and Preclinical Evaluation of a Copper-Based Acidic Hydrogel for Atopic Dermatitis
Zhongjin Huang1,2, Guoxin Du2, Minghu Chen2
1Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Pharmaceutical Development and Technology
|August 7, 2026
Summary
A new acidic hydrogel with copper ions effectively treats atopic dermatitis (AD) by lowering skin pH and killing bacteria. This non-steroidal treatment shows promising results and a good safety profile for AD management.
Area of Science:
- Dermatology
- Materials Science
- Microbiology
Background:
- Atopic dermatitis (AD) is characterized by a compromised skin barrier, elevated skin pH, and increased Staphylococcus aureus colonization.
- Restoring acidic skin pH and controlling microbial overgrowth are key non-steroidal therapeutic strategies for AD.
Purpose of the Study:
- To develop and evaluate a novel copper-based acidic hydrogel for its properties, antimicrobial efficacy, and safety.
- To assess the hydrogel's potential as a non-steroidal treatment for atopic dermatitis.
Main Methods:
- A copper-based acidic hydrogel (pH ~3.2) was formulated using basic copper carbonate, acetic acid, and xanthan gum.
- Characterization included rheology, stability testing, antimicrobial activity assays against S. aureus, E. coli, and C. albicans, efficacy studies in AD-like mice, and dermal safety tests in rabbits.
Main Results:
- The hydrogel demonstrated excellent stability and gel-like properties.
- It exhibited rapid and potent broad-spectrum antimicrobial activity, eradicating >99.6% of tested pathogens within 10 minutes.
- In vivo studies showed dose-dependent reduction in AD-like lesions, ear swelling, and inflammation, with only mild, reversible irritation in rabbits.
Conclusions:
- The copper-based acidic hydrogel possesses significant antimicrobial properties and effectively ameliorates AD-like skin conditions.
- Its favorable short-term safety profile supports its further development as a non-steroidal topical treatment for atopic dermatitis.
